Sanofi
Exendin-4 derivatives as dual GLP1/glucagon agonists

Abstract:

The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.